Iron Sulfate for Iron Deficiency Anemia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Iron Deficiency AnemiaIron Sulfate - Drug
Eligibility
7 - 4
All Sexes
What conditions do you have?
Select

Study Summary

This trial looks at whether giving iron supplements to premature babies earlier can help improve their neurological development.

Eligible Conditions
  • Iron Deficiency Anemia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
SP-420
1
Darbepoetin Alfa
1
Iron Sucrose

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 22-26 months corrected age

22-26 months corrected age
Neurodevelopmental outcome in participants
Week 40
Adrenal gland hypofunction
Iron insufficiency as assessed by hemoglobin level (g/dL)
Iron insufficiency as assessed by reticulocyte count (%)
Iron insufficiency as assessed by reticulocyte hemoglobin equivalent (Ret-He, pg)
Week 16
Assess whether measurement of ferritin (ng/mL) or hemoglobin (g/dL) is superior in guiding intervention of iron-insufficiency
Assess whether measurement of ferritin (ng/mL) or reticulocyte count (%) is superior in guiding intervention of iron-insufficiency

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
SP-420
2
Darbepoetin Alfa
1
Iron Sucrose

Trial Design

2 Treatment Groups

Standard iron dose
1 of 2
Early, high-dose iron
1 of 2

Active Control

Experimental Treatment

90 Total Participants · 2 Treatment Groups

Primary Treatment: Iron Sulfate · No Placebo Group · N/A

Early, high-dose iron
Drug
Experimental Group · 1 Intervention: Iron Sulfate · Intervention Types: Drug
Standard iron dose
Drug
ActiveComparator Group · 1 Intervention: Iron Sulfate · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 22-26 months corrected age

Who is running the clinical trial?

Ann & Robert H Lurie Children's Hospital of ChicagoLead Sponsor
232 Previous Clinical Trials
5,178,168 Total Patients Enrolled
Janine Y Khan, MD, MBAPrincipal InvestigatorAnn & Robert H Lurie Children's Hospital of Chicago

Eligibility Criteria

Age 7 - 4 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Infants who are more than one week old and can tolerate at least 60ml/kg/day of feed through their stomachs are considered eligible for enrollment in the study.
The study included NICU inpatients between 24-0/7 and 30-6/7 weeks of gestation.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top